Intelligence desk

Products

Signal Tracker Data Platform Data Enrichment API

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
CPTx logo — Pioneering the development of in vivo genetic medicines buil...

CPTx

Pioneering the development of in vivo genetic medicines built with single-stranded DNA.

Founded 2021 Germany Planegg, Germany 46 employees

General Information

Company Name CPTx
Founded Year 2021
Location Germany Planegg, Germany +1
Employees 46
Social

Get notified when CPTx moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

AI Insight

Bounce Watch AI
2 months ago

CPTx is exhibiting strategic momentum by strengthening its executive team with the appointment of Edward Rebar as Chief Scientific Officer. This key hire in scientific leadership, coupled with their upcoming participation in the Jefferies Global Healthcare Conference, indicates a concerted effort to accelerate scientific development and enhance visibility within the healthcare investment community. These synchronized actions suggest the company is positioning itself for significant future growth and potential funding discussions.

Signal Types
Hiring Event Participation
Strategic Labels
Executive Team Strengthening Scientific Leadership Industry Engagement
Next Move: Fundraising
·
Impact: 8/10
·
Ideal For: Biotech VCs — Genetic Medicines, Early-Stage Life Sciences Investors

About CPTx

CPTx, founded in 2021, is at the forefront of genetic medicine innovation, specializing in the development of in vivo genetic medicines utilizing single-stranded DNA. This pioneering approach positions CPTx in a unique niche within the biotechnology sector, where the demand for novel genetic therapies is burgeoning.

The company's slogan, "Pioneering the development of in vivo genetic medicines built with single-stranded DNA," effectively encapsulates its mission and commitment to advancing genetic solutions. While there is currently no disclosed information about its headquarters, specific industries, or recent investment details, CPTx represents a promising opportunity for investors seeking to capitalize on cutting-edge genetic technology advancements.

Taxonomy: in vivo genetic medicines, single-stranded DNA, genetic medicine development, DNA therapeutics, pharmaceutical innovation, gene therapy, DNA-based treatments, medical biotechnology, therapeutic innovation, biopharmaceuticals, precision medicine, molecular genetics, genomic medicine

Services & Products

Development of in vivo CAR-T therapies
Genetic medicine pipeline advancement
Custom ssDNA manufacturing
Partnerships for research and clinical programs

Target Customers

Patients needing genetic therapies Cancer treatment facilities Biotechnology researchers Pharmaceutical companies

No funding data available for CPTx yet.

Get notified when CPTx raises funding

CPTx Alternatives & Competitors

CPTx vs
CRI Genetics
CRI Genetics United States

Our mission at CRI Genetics is to unlock complex information in your genetics to educate and empower...

39 employees
Biotechnology, Life Sciences
CPTx vs
NGeneR
NGeneR Denmark

Make every day progress for better health.

2-10 employees
Biotechnology, Health Care
CPTx vs
Lobo Genetics
Lobo Genetics Canada

Ensuring a safer cannabis experience through genetics.

Series Unknown
11-50 employees
Biotechnology, Health Care

FAQ About CPTx

Pioneering the development of in vivo genetic medicines built with single-stranded DNA.
CPTx was founded in 2021.
CPTx is headquartered in Planegg, Germany.
CPTx has approximately 46 employees.
CPTx offers: Development of in vivo CAR-T therapies, Genetic medicine pipeline advancement, Custom ssDNA manufacturing, Partnerships for research and clinical programs.
Top alternatives and competitors to CPTx include CRI Genetics, NGeneR, Lobo Genetics, Artemis Health Inc, Genotek. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CPTx and CRI Genetics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors CPTx and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy